Insider · CIK 0001688192
Douglas A Treco
Files at CRSP (CRISPR Therapeutics AG), INZY (Inozyme Pharma, Inc.). First filing Apr 3, 2025, latest Aug 8, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRSP: CRISPR Therapeutics AG
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | CRSPbuy CRISPR Therapeutics AG | $1.1M 20,000 shares | +1000% | +80% from low-17% from high | |
| 15Weak | INZYsell Inozyme Pharma, Inc. | $7,849 8,819 shares | -18% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | CRSP CRISPR Therapeutics AG | POpen-market purchase Common Shares | +20,000 | $57.03 | $1.1M | 22,000 | Aug 8, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | UTender of shares Common Stock | -43,861 | $4.00 | $175k | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -150,000 | - | - | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -86,979 | - | - | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -400,000 | - | - | 0 | Jul 3, 2025 |
| Jun 25, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Common Stock | +2,815 | $0.74 | $2,083 | 43,861 | Jun 27, 2025 |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
| Apr 1, 2025 | INZY Inozyme Pharma, Inc. | MOption exercise Common Stock | +25,000 | - | - | 49,865 | Apr 3, 2025 |
| Apr 2, 2025 | INZY Inozyme Pharma, Inc. | SOpen-market sale Common Stock | -8,819 | $0.89 | $7,849 | 41,046 | Apr 3, 2025 |
| Apr 1, 2025 | INZY Inozyme Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -25,000 | $0.00 | $0 | 50,000 | Apr 3, 2025 |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Mar 17, 2025 |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +100,000 | $0.00 | $0 | 100,000 | Mar 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.